Testing effectiveness (Phase 2)Active Not RecruitingNCT04294264
What this trial is testing
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
Who this might be right for
Metastatic Colorectal CarcinomaRecurrent Colon CarcinomaRefractory Colorectal Carcinoma+3 more
Rutgers, The State University of New Jersey 50